Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SB Opportunity Fund (later rebranded and spun out as Open Opportunity Fund) is a SoftBank-anchored venture capital fund launched in 2020 to invest in technology startups led by Black, Latinx and Native American founders across sectors such as enterprise IT, fintech and health tech, with no direct drug development or clinical pipeline.[1][5][9][10][11][12][3][7]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SB Opportunity Fund.